Save time and get answers to complex questions with AI chat
Patent expiration date of guselkumab?Complera manufacturer?What's the advised delay for milk post lipitor?Zemdri nce gain exclusivity 2028 patent 2031?Patent tenofovir alafenamide gilead?
See the DrugPatentWatch profile for Adzenys
Adzenys (amphetamine) is sold as an extended-release medicine. The available dosing strengths are: - 3.1 mg - 6.3 mg - 9.4 mg - 12.5 mg - 15.7 mg - 18.8 mg
Typical dosing starts at a lower strength and is adjusted upward based on response and tolerability. The goal is to find the lowest effective dose that controls symptoms without causing unacceptable side effects.
Adzenys is used for ADHD in children and adults, and dose selection depends on factors like age, symptom control, and side-effect history. Patients who switch from another amphetamine or stimulant are often started at a conservative strength to reduce the risk of adverse effects.
Other Questions About Adzenys :